Andexanet alfa in acute aortic syndrome: first UK experience

Abstract

Andexanet alfa was employed to reverse the anticoagulant effect of direct oral anticoagulants in 3 patients who required emergent surgery for repair of type A aortic dissection. Its use was instrumental in securing haemostasis. However, we caution against the administration of Andexanet alfa prior to cardiopulmonary bypass as it can induce heparin resistance and complicate the perioperative monitoring of anticoagulation during cardiopulmonary bypass.

Keywords: Acute aortic syndrome; Andexanet alfa; Aorta; Bleeding; Emergency.